期刊文献+

联合脏器切除治疗进展期胃癌 被引量:2

下载PDF
导出
摘要 本文报告联合脏器切除治疗进展期胃癌96例,其中联合脾和/或胰切除75例,横结肠17例,胆囊和部分肝4例。与同期治疗的128例进展期胃癌相比较,明显提高了病人的生存质量及存活期。
出处 《内蒙古医学杂志》 1995年第6期321-322,共2页 Inner Mongolia Medical Journal
  • 相关文献

参考文献1

二级参考文献7

  • 1Etsuro Yanagawa MD,Tetsuya Toge,Akihiro Sawamura,Yasuhide Kegoya,Nobutoshi Baba,Takao Hattori. The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients[J] 1988,The Japanese Journal of Surgery(6):660~667
  • 2Jun Soga M.D.,Shinichi Ohyama M.D.,Kaoru Miyashita M.D.,Tsutomu Suzuki M.D.,Atsushi Nashimoto M.D.,Otsuo Tanaka M.D.,Kohichi Sasaki M.D.,Terukazu Muto M.D.. A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure[J] 1988,World Journal of Surgery(3):398~404
  • 3Tetsuya Toge MD,Yoshihiro Seto,Katsumasa Kuroi,Hirofumi Yamada,Kiyoshi Aratani,Tsuyoshi Fujita,Etsuro Yanagawa,Takao Hattori. Relationship of the distribution of leu-2+ cells with suppressor cell activities in the spleen and lymphnodes from gastric cancer[J] 1987,The Japanese Journal of Surgery(2):72~77
  • 4Tetsuya Toge MD,Akira Kameda,Hirofumi Yamada,Yoshihiro Seto,Kiyoshi Aratani,Tsuyoshi Fujita,Takao Hattori. Role of the spleen on immunosuppression in esophageal and gastric cancer[J] 1986,The Japanese Journal of Surgery(5):330~335
  • 5Yoshifumi Kodama M.D.,Keizo Sugimachi M.D.,Kazuhiko Soejima M.D.,Toshimitsu Matsusaka M.D.,Kiyoshi Inokuchi M.D., Ph.D., F.A.C.S.. Evaluation of extensive lymph node dissection for carcinoma of the stomach[J] 1981,World Journal of Surgery(2):241~246
  • 6陈峻青.胃癌外科治疗进展[J].实用外科杂志,1991,11(8):426-429. 被引量:60
  • 7朱正纲,陈雪华,纪玉宝,尹浩然,朱寿柱,林言箴.实验性胃癌大鼠脾脏免疫杀伤细胞活性的研究[J].中国免疫学杂志,1991,7(6):364-366. 被引量:8

共引文献8

同被引文献16

  • 1徐大志,詹友庆.胃癌切缘残留癌[J].国外医学(肿瘤学分册),2004,31(7):532-534. 被引量:3
  • 2洪坚善,张传珉,杨南武,陈建思,陈汉华,杨华伟.胃近端癌和远端癌的预后比较[J].医学临床研究,2005,22(10):1423-1424. 被引量:5
  • 3周振玉,郭澎涛,徐惠绵.胃上部癌联合脾切除术的评价与进展[J].国际肿瘤学杂志,2006,33(2):138-141. 被引量:1
  • 4Ajani JA,Mansfield PF,Janjan N,et al.Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma[J].J Clin Oncol,2004,22(14):2774-2780.
  • 5Fabo P, Valerio P, Paola C, et al. Proximal compared with distal gastrie cancer [J]. The American Surgeon, 2001, 67 (7) : 697- 703.
  • 6Marrelli D, Pedrazzani C, Neri A, et al. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis ofpotential risk factors [J]. Ann Surg Oncot, 2007, 14 (1): 25-33.
  • 7Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy veIBus D2 total gastrectomy plus splenectomy in 187 patienlswith gastric caminoma[J]. Surgery, 2002. 131 (4): 401-407.
  • 8Erturk S, Eman Y, Clock Y, et al. Effect of simultmmons splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma [J]. Surg Today. 2003, 33(4): 254-258.
  • 9苏江.多脏器切除在进展期胃癌手术中的临床应用[J].中国现代医药杂志,2007,9(10):45-46. 被引量:1
  • 10许琳,赵东明,王青.进展期胃癌患者脾脏免疫功能测定分析[J].山东医药,2001,41(13):24-25. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部